Human iPSC-Derived Atrial Cardiomyocytes

MS
DS

产品描述（Product Details）

Human iPSC-Derived Atrial Cardiomyocytes are specialized cells that closely mimic the properties of human atrial heart cells, essential for cardiovascular research and drug development. Our Human iPSC-Derived Atrial Cardiomyocytes are differentiated from human induced pluripotent stem cells (iPSCs) using a fully defined, proprietary cardiac differentiation protocol.

These cardiomyocytes are thoroughly characterized through immunocytochemistry, targeting well-known markers such as MYL7 and cTNT, ensuring their atrial-specific identity and functionality. They have been validated for their ability to exhibit atrial-like electrophysiological properties and responsiveness to cardiotoxic drugs.

Additionally, our atrial cardiomyocytes are cryopreserved at an optimal stage of differentiation, ensuring their functionality and readiness for immediate use upon thawing. This guarantees a consistent and reliable cell source for research into atrial fibrillation, atrial-specific cardiac conditions, and cardiac toxicity testing.

产品特征（Product Specification）

Cryopreserved cells, shipped on dry ice. Each vial contains over 1 x 10^6 cells.

存储（Storage）

Frozen in liquid nitrogen.

质量管理控制体系（QMS）

1. 质量管理体系（ISO, GMP）
2. 质量优势
3. 质控流程